Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Am Chem Soc ; 141(6): 2201-2204, 2019 02 13.
Artigo em Inglês | MEDLINE | ID: mdl-30698425

RESUMO

Bacterial capsular polysaccharides are important virulence factors. Capsular polysaccharides from several important Gram-negative pathogens share a conserved glycolipid terminus containing 3-deoxy-ß-d- manno-oct-2-ulosonic acid (ß-Kdo). The ß-Kdo glycosyltransferases responsible for synthesis of this conserved glycolipid belong to a new family of glycosyltransferases that shares little homology with other such enzymes, thereby representing an attractive antivirulence target. Here, we report the development of a fluorescence polarization-based, high-throughput screening assay (FP-tag) for ß-Kdo glycosyltransferases, and use it to identify a class of marine natural products as lead inhibitors. This "FP-tag" assay should be readily adaptable to high-throughput screens of other glycosyltransferases.


Assuntos
Inibidores Enzimáticos/farmacologia , Glicosiltransferases/antagonistas & inibidores , Química Click , Avaliação Pré-Clínica de Medicamentos , Inibidores Enzimáticos/química , Ensaios de Triagem em Larga Escala , Concentração Inibidora 50 , Açúcares Ácidos/química , Açúcares Ácidos/farmacologia
2.
Chembiochem ; 11(14): 2026-33, 2010 Sep 24.
Artigo em Inglês | MEDLINE | ID: mdl-20715263

RESUMO

A collection of new reversible glycosidase inhibitors of the iminoalditol type featuring N-substituents containing perfluorinated regions has been prepared for evaluation of physicochemical, biochemical and diagnostic properties. The vast variety of feasible oligofluoro moieties allows for modular approaches to customised structures according to the intended applications, which are influenced by the fluorine content as well as the distance of the fluorous moiety from the ring nitrogen. The first examples, in particular in the D-galacto series, exhibited excellent inhibitory activities. A preliminary screen with two human cell lines showed that, at subinhibitory concentrations, they are powerful pharmacological chaperones enhancing the activities of the catalytically handicapped lysosomal D-galactosidase mutants associated with GM1 gangliosidosis and Morquio B disease.


Assuntos
Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Galactosidases/antagonistas & inibidores , Gangliosidose GM1/tratamento farmacológico , Álcoois Açúcares/química , Álcoois Açúcares/farmacologia , Linhagem Celular , Café/enzimologia , Inibidores Enzimáticos/uso terapêutico , Escherichia coli/enzimologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/enzimologia , Galactosidases/metabolismo , Halogenação , Humanos , Iminas/química , Iminas/farmacologia , Iminas/uso terapêutico , Rhizobium/enzimologia , Álcoois Açúcares/uso terapêutico
3.
Bioorg Med Chem Lett ; 20(14): 4077-9, 2010 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-20610152

RESUMO

Biotin-iminosugar conjugates of different configuration such as D-gluco, D-galacto, L-ido as well as a furanoid representative in the D-manno configuration have been synthesised and exhibit powerful inhibition of beta-glucosidase from Agrobacterium sp. with K(i) values in the range of the respective parent compounds. Such molecular probes have potential for activity-based protein profiling taking advantage of the biotin-(strept)avidin interaction.


Assuntos
Biotina/síntese química , Biotina/farmacologia , Álcoois Açúcares/síntese química , Álcoois Açúcares/farmacologia , Avaliação Pré-Clínica de Medicamentos , Sondas Moleculares
4.
Biochemistry ; 47(38): 10058-68, 2008 Sep 23.
Artigo em Inglês | MEDLINE | ID: mdl-18759458

RESUMO

The N-glycosylation pathway is a target for pharmaceutical intervention in a number of pathological conditions including cancer. Golgi alpha-mannosidase II (GMII) is the final glycoside hydrolase in the pathway and has been the target for a number of synthetic efforts aimed at providing more selective and effective inhibitors. Drosophila GMII (dGMII) has been extensively studied due to the ease of obtaining high resolution structural data, allowing the observation of substrate distortion upon binding and after formation of a trapped covalent reaction intermediate. However, attempts to find new inhibitor leads by high-throughput screening of large commercial libraries or through in silico docking were unsuccessful. In this paper we provide a kinetic and structural analysis of five inhibitors derived from a small glycosidase-focused library. Surprisingly, four of these were known inhibitors of beta-glucosidases. X-ray crystallographic analysis of the dGMII:inhibitor complexes highlights the ability of the zinc-containing GMII active site to deform compounds, even ones designed as conformationally restricted transition-state mimics of beta-glucosidases, into binding entities that have inhibitory activity. Although these deformed conformations do not appear to be on the expected conformational itinerary of the enzyme, and are thus not transition-state mimics of GMII, they allow positioning of the three vicinal hydroxyls of the bound gluco-inhibitors into similar locations to those found with mannose-containing substrates, underlining the importance of these hydrogen bonds for binding. Further, these studies show the utility of targeting the acid-base catalyst using appropriately positioned positively charged nitrogen atoms, as well as the challenges associated with aglycon substitutions.


Assuntos
Inibidores Enzimáticos/química , Glicosídeo Hidrolases/antagonistas & inibidores , Glicosídeo Hidrolases/química , Complexo de Golgi/enzimologia , Manosidases/antagonistas & inibidores , Manosidases/química , Animais , Células Cultivadas , Cristalografia por Raios X , Drosophila melanogaster/efeitos dos fármacos , Drosophila melanogaster/enzimologia , Avaliação Pré-Clínica de Medicamentos , Inibidores Enzimáticos/farmacologia , Complexo de Golgi/efeitos dos fármacos , Estrutura Secundária de Proteína/efeitos dos fármacos , Estrutura Secundária de Proteína/fisiologia , Proteínas/antagonistas & inibidores , Proteínas/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA